These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32869036)

  • 1. Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile.
    Vatsalya V; Li F; Frimodig JC; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ
    medRxiv; 2020 Aug; ():. PubMed ID: 32869036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile.
    Vatsalya V; Li F; Frimodig J; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ
    Front Pharmacol; 2020; 11():598128. PubMed ID: 33737877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
    Ciampa ML; O'Hara TA; Joel CL; Gleaton MM; Tiwari KK; Boudreaux DM; Prasad BM
    Infect Dis Rep; 2021 Apr; 13(2):377-387. PubMed ID: 33921604
    [No Abstract]   [Full Text] [Related]  

  • 6. Encephalopathy responsive to thiamine in severe COVID-19 patients.
    Branco de Oliveira MV; Irikura S; Lourenço FHB; Shinsato M; Irikura TCDB; Irikura RB; Albuquerque TVC; Shinsato VN; Orsatti VN; Fontanelli AM; Samegima DAG; Gonçalves MVM; Bernabé DG
    Brain Behav Immun Health; 2021 Jul; 14():100252. PubMed ID: 33817670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
    Shibabaw T
    J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
    Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.
    Guo H; Sheng Y; Li W; Li F; Xie Z; Li J; Zhu Y; Geng J; Liu G; Wang L; Li J; Wang F
    Front Med (Lausanne); 2020; 7():572989. PubMed ID: 33195321
    [No Abstract]   [Full Text] [Related]  

  • 10. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
    Alunno A; Carubbi F; Rodríguez-Carrio J
    RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
    Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S
    Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm.
    Shekhawat J; Gauba K; Gupta S; Purohit P; Mitra P; Garg M; Misra S; Sharma P; Banerjee M
    Indian J Clin Biochem; 2021 Oct; 36(4):440-450. PubMed ID: 34177139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine Storm and Neuropathological Alterations in Patients with Neurological Manifestations of COVID-19.
    Tsagkaris C; Bilal M; Aktar I; Aboufandi Y; Tas A; Aborode AT; Suvvari TK; Ahmad S; Shkodina A; Phadke R; Emhamed MS; Baig AA; Alexiou A; Ashraf GM; Kamal MA
    Curr Alzheimer Res; 2022; 19(9):641-657. PubMed ID: 36089786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
    Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
    Front Immunol; 2020; 11():603389. PubMed ID: 33552062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA.
    Khodadadi H; Salles ÉL; Jarrahi A; Chibane F; Costigliola V; Yu JC; Vaibhav K; Hess DC; Dhandapani KM; Baban B
    Cannabis Cannabinoid Res; 2020; 5(3):197-201. PubMed ID: 32923657
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients.
    Zeng J; Xie MH; Yang J; Chao SW; Xu EL
    World J Clin Cases; 2020 Sep; 8(17):3763-3773. PubMed ID: 32953852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Management of Cytokine Storm in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2020 Jul; 52(3):306-313. PubMed ID: 33020343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; Pardo CA
    medRxiv; 2021 Jan; ():. PubMed ID: 33469596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.